Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease
- PMID: 20089913
- PMCID: PMC2866050
- DOI: 10.1523/JNEUROSCI.4188-09.2010
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease
Abstract
Imaging studies show that Parkinson's disease (PD) alters the activity of motor- and cognition-related metabolic brain networks. However, it is not known whether the network changes appear at or before symptom onset. In this study, we examined 15 hemiparkinsonian patients who underwent serial metabolic imaging with [(18)F]-fluorodeoxyglucose (FDG) PET at baseline and again 2.1 +/- 0.6 (mean +/- SD) and 3.9 +/- 0.7 years later. We assessed longitudinal changes in network activity in each cerebral hemisphere, focusing specifically on the "presymptomatic" hemisphere--ipsilateral to the initially involved body side. At the network level, the activity of the PD motor-related pattern (PDRP) increased symmetrically in both hemispheres over time (p < 0.001), with significant bilateral elevations at each of the three time points. Hemispheric expression of the PD cognition-related pattern likewise increased symmetrically (p < 0.001), although significant elevations were not evident on either side until 4 years. At the regional level, putamen metabolism contralateral to the initially affected body side was elevated at all three time points, without longitudinal change. In contrast, in the initially presymptomatic hemisphere, putamen metabolic activity increased steadily over time, reaching abnormal levels only at 4 years. Metabolic activity in the contralateral precuneus fell to subnormal levels by the final time point. These findings suggest that abnormal PDRP activity antecedes the appearance of motor signs by approximately 2 years. The timing and laterality of symptom onset relates to focal asymmetric metabolic changes at the putamenal node of this network.
Figures
Similar articles
-
Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.J Parkinsons Dis. 2020;10(4):1737-1749. doi: 10.3233/JPD-202117. J Parkinsons Dis. 2020. PMID: 32925097
-
Changes in network activity with the progression of Parkinson's disease.Brain. 2007 Jul;130(Pt 7):1834-46. doi: 10.1093/brain/awm086. Epub 2007 Apr 30. Brain. 2007. PMID: 17470495 Free PMC article.
-
Hemispheric specialization of the basal ganglia during vocal emotion decoding: Evidence from asymmetric Parkinson's disease and 18FDG PET.Neuropsychologia. 2018 Oct;119:1-11. doi: 10.1016/j.neuropsychologia.2018.07.023. Epub 2018 Jul 21. Neuropsychologia. 2018. PMID: 30040955
-
Dopaminergic function and progression of Parkinson's disease: PET findings.Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S38-40. doi: 10.1016/S1353-8020(09)70833-8. Parkinsonism Relat Disord. 2009. PMID: 20123555 Review.
-
Metabolic imaging and plasticity.Handb Clin Neurol. 2022;184:121-132. doi: 10.1016/B978-0-12-819410-2.00006-0. Handb Clin Neurol. 2022. PMID: 35034729 Review.
Cited by
-
Validation of nigrostriatal positron emission tomography measures: critical limits.Ann Neurol. 2013 Mar;73(3):390-6. doi: 10.1002/ana.23798. Epub 2013 Feb 19. Ann Neurol. 2013. PMID: 23423933 Free PMC article.
-
Parkinson's disease cognitive network correlates with caudate dopamine.Neuroimage. 2013 Sep;78:204-9. doi: 10.1016/j.neuroimage.2013.03.070. Epub 2013 Apr 8. Neuroimage. 2013. PMID: 23578575 Free PMC article.
-
Metabolic brain networks in translational neurology: concepts and applications.Ann Neurol. 2012 Nov;72(5):635-47. doi: 10.1002/ana.23631. Epub 2012 Aug 31. Ann Neurol. 2012. PMID: 22941893 Free PMC article. Review.
-
Effects of levodopa on regional cerebral metabolism and blood flow.Mov Disord. 2015 Jan;30(1):54-63. doi: 10.1002/mds.26041. Epub 2014 Oct 9. Mov Disord. 2015. PMID: 25296957 Free PMC article. Review.
-
Network Structure and Function in Parkinson's Disease.Cereb Cortex. 2018 Dec 1;28(12):4121-4135. doi: 10.1093/cercor/bhx267. Cereb Cortex. 2018. PMID: 29088324 Free PMC article.
References
-
- Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci. 2003;26:215–221. - PubMed
-
- Buhmann C, Binkofski F, Klein C, Büchel C, van Eimeren T, Erdmann C, Hedrich K, Kasten M, Hagenah J, Deuschl G, Pramstaller PP, Siebner HR. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain. 2005;128:2281–2290. - PubMed
-
- Dhawan V, Eidelberg D. PET imaging in Parkinson's disease and other neurodegenerative disorders. In: Gilman S, editor. The neurobiology of disease. San Diego: Academic; 2006. pp. 821–828.
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR018535/RR/NCRR NIH HHS/United States
- P50 NS038370-040005/NS/NINDS NIH HHS/United States
- P50 NS 38370/NS/NINDS NIH HHS/United States
- R01 NS035069-04/NS/NINDS NIH HHS/United States
- R01 NS035069-08/NS/NINDS NIH HHS/United States
- P50 NS038370-030005/NS/NINDS NIH HHS/United States
- R01 NS035069-05A1/NS/NINDS NIH HHS/United States
- P50 NS038370-01A1S10005/NS/NINDS NIH HHS/United States
- R01 NS035069-06/NS/NINDS NIH HHS/United States
- P50 NS038370-01A10005/NS/NINDS NIH HHS/United States
- P50 NS038370/NS/NINDS NIH HHS/United States
- R01 NS 35069/NS/NINDS NIH HHS/United States
- P50 NS038370-050005/NS/NINDS NIH HHS/United States
- R01 NS035069/NS/NINDS NIH HHS/United States
- P50 NS038370-020005/NS/NINDS NIH HHS/United States
- R01 NS035069-07/NS/NINDS NIH HHS/United States
- M01 RR018535-056239/RR/NCRR NIH HHS/United States
- M01 RR018535-065456/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical